A study to assess Long-Term Outcome of Chronic Phase Chronic Myeloid Leukemia Patients Treated with Nilotinib as Front-Line therapy
Latest Information Update: 11 Jan 2021
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Adverse reactions; Therapeutic Use
- 11 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology